So far, China has made no official public threat about weaponizing its dominant position in this segment of the ...

Biocytogen secures Japanese patent for RenMab platform; expands global patent portfolio for RenMice fully human antibody: Beijing Saturday, June 7, 2025, 11:00 Hrs [IST] Biocytoge ...

In recent years, Chinese investment in U.S. and global biotech and medtech has increased significantly. These partnerships ...

The president’s proposed 25 percent tariffs on pharmaceutical imports will be catastrophic. There are other options to bring ...

As a leader in its category, Sinotau is probably hoping to follow in the footsteps of Hengrui Pharmaceuticals (1276.HK; ...

SINGAPORE—China is racing toward economic self-sufficiency by weaning itself off American technology. But it has made a ...

U.S. dependency on China for critical goods like rare earths and pharmaceuticals poses risks. Trump's strategies aim to ...

Biocytogen and Nanjing Chia Tai Tianqing Announce IND Approval in China for Co-Developed Anti-IGF-1R Antibody NTB003 (BCG009) ...

Beijing has approved more export licenses for the critical minerals and magnets in recent days, but supplies remain scarce ...

Adani Group stocks, United Breweries, HCL Tech, Glenmark Pharma, NTPC Green and Jindal Stainless are among the stocks to ...

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

Home builders, car manufacturers and can makers are among those that will see higher prices for materials. Those companies ...